Affini-T
Affini-T Therapeutics | Unlocking the power of T cells
Affini-T is headquartered in United States.
- Business Model
- B2B
- Website
- affinittx.com
About
Affini-T Therapeutics is a clinical-stage precision immunotherapy company that unlocks the power of T cells and targets core oncogenic driver mutations, beginning with KRAS, to develop potentially curative therapies for patients with solid tumor cancers. The company is advancing oncogenic-driver programs including TP53 R175H, KRAS G12D, and KRAS G12V, and has presented CRISPR gene-editing and trial-in-progress data at scientific meetings. Affini-T licenses pipeline programs from leading comprehensive cancer centers and focuses on discovery and development of innovative T-cell therapies.
Summary
Affini-T is a Biotech company based in United States.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/affini-t"><img src="https://indexed.vc/api/badge/company/affini-t" alt="Affini-T on Indexed.vc" width="260" height="76" /></a>